Recipient of a Penn Center for Precision Medicine Accelerator Fund award in 2017, Sony Tuteja-Stevens, PharmD, MS, describes efforts to incorporate pharmacogenetics into clinical practice at Penn Medicine. A promising application, pharmacogenetics uses a patient’s genotype to predict drug responses and the risk of adverse effects.
A pharmacogenetics researcher, Dr. Tuteja-Stevens is a Research Associate in the Department of Translational Medicine & Human Genetics at Penn Medicine.
Related Links
Visit the Division of Translational Medicine & Human Genetics at Penn Medicine
Personalized Diagnostics for Hematologic and Solid Tumor Cancers
Published
July 19, 2017
Created by
BROADCASTMED